A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic Carcinoma

This study has been completed.
Sponsor:
Collaborator:
Green Cross Corporation
Information provided by:
Jennerex Biotherapeutics
ClinicalTrials.gov Identifier:
NCT00629759
First received: February 26, 2008
Last updated: January 3, 2013
Last verified: February 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2007
  Primary Completion Date: July 2007 (Final data collection date for primary outcome measure)
No publications provided by Jennerex Biotherapeutics

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):